The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
What is the situation with Italy, we are now into March and nothing, thought it was ready for commissioning back in December? Or is DP waiting to release a string of game changing RNSs?
I assume with the $1m upfront cash no placing is required? The RNS did'nt exactly clarify this. Is ECHO now cash flow positive? Any opinions?
FWIW I would rather buy now at 0.4p than before today.
In the present climate any placings appear to be at huge discount, hence today. From todays level this has to be a potential 10 bagger over the next 2 years if all goes well. At 8p the MC was £60m after the placing the MC £9m with £6m in cash. A no brainer.
FWIW some amount of buying after the huge drop.
Previous RNS "Lyn Rees (independent non-executive director) resigned as non-executive director of the Company effective 30 September 2022 to focus on his responsibilities outside of the Company. We would like to place on record our thanks and appreciation to Lyn for his support and valued advice over the past three years." I assume this is the same CEO of Yourgene losing 80% of its SP today after a RI at 80% discount.
This had a market cap of £100m when sp £1.00. At recent 20p the market cap was £20m. After the placing shares are issued the market cap will be £4.75m with £3.75m in cash. Surely this is a steal to buy in at these levels, 10 bagger over the next 12 months?
Ooops
If this company is currently making £5m per annum profit and has £5-7m in cash the market cap of £10m is no brainer. UJO 5 bagged from January to September and same with EDR. Sentiment will change in due course with potential increase in production from Wressle and the gas being piped up along with the Irish gas. Could and should start with a share buy back at these levels once the £2m from Serenity is released.